NCT01249352 2025-03-31
NICE
Eurofarma Laboratorios S.A.
Phase 2/3 Completed
Clinical Trials
4 trialsNCT00113256 2024-08-02
Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer
Astex Pharmaceuticals, Inc.
Phase 2/3 Terminated
NCT00443196 2018-03-12
Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas
Pierian Biosciences
Phase 2/3 Completed
NCT00127478 2007-11-29
A Long Term Safety Study With Atrasentan
Abbott
Phase 2/3 Completed